CANCER IMMUNOTHERAPY. Baby's leukemia recedes after novel cell therapy

Science. 2015 Nov 13;350(6262):731. doi: 10.1126/science.350.6262.731.
No abstract available

Publication types

  • News

MeSH terms

  • Alemtuzumab
  • Antibodies, Monoclonal, Humanized / therapeutic use
  • Antineoplastic Agents / therapeutic use
  • Cell- and Tissue-Based Therapy / methods*
  • Female
  • Genetic Engineering
  • Genome, Human
  • Humans
  • Immunotherapy / methods*
  • Infant
  • Leukemia / therapy*
  • London
  • T-Lymphocytes / immunology
  • T-Lymphocytes / transplantation*
  • Treatment Outcome

Substances

  • Antibodies, Monoclonal, Humanized
  • Antineoplastic Agents
  • Alemtuzumab